In DLBCL, intratumoral FOXP3+ Tregs are reported to be associated with superior prognosis, especially in the GCB type, but with poor prognosis in the non-GCB type [77, 78]. The gene discussed is FOXP3; the disease is diffuse large B-cell lymphoma.